RxDoctor Payments Data

Olusola Asafa

Physician Assistant · Oroville, CANPI 1467969485

Payments from drug & device makers

$2,499in general payments, 2019–2025

Across 112 payments — averaging $22.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$659
  • Pfizer$334
  • Novo Nordisk$314
  • AbbVie$253
  • Bayer$222
  • Viiv Healthcare Company$201
  • plus $516 from 11 others

What the payments were for

  • Food & beverage$2,499100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,499 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide162$168,759
JardianceEmpagliflozin73$94,969
FarxigaDapagliflozin Propanediol59$70,811
EliquisApixaban44$38,715
TrulicityDulaglutide37$35,508
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl201$33,388
KerendiaFinerenone42$32,776
BelsomraSuvorexant56$24,317
Tresiba Flextouch U-100Insulin Degludec46$21,708
JanuviaSitagliptin Phosphate15$19,281
ProliaDenosumab11$16,943
RybelsusSemaglutide14$15,194
Lidocaine25$13,995
Victoza 3-PakLiraglutide13$13,738
XareltoRivaroxaban14$13,327

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$314$183,953176 claims
AstraZenecaFarxiga, Brilinta$15$75,95671 claims
MerckBelsomra, Januvia$659$43,59871 claims
PfizerEliquis$334$38,71544 claims
Lilly USA, LLCTrulicity, Olanzapine$74$37,04875 claims
BayerKerendia$222$32,77642 claims
Johnson & JohnsonXarelto$19$13,32714 claims
GSKBreo Ellipta$18$4,92213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Oroville

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →